Aspiriant LLC’s Booking.com BKNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Sell
1,300
-425
-25% -$78.2K 0.01% 323
2025
Q4
$370K Buy
1,725
+450
+35% +$92.6K 0.01% 249
2025
Q3
$275K Sell
1,275
-500
-28% -$112K 0.01% 263
2025
Q2
$411K Buy
1,775
+425
+31% +$87K 0.01% 220
2025
Q1
$249K Buy
1,350
+50
+4% +$9.56K 0.01% 260
2024
Q4
$258K Buy
1,300
+25
+2% +$4.8K 0.01% 253
2024
Q3
$215K Sell
1,275
-100
-7% -$15.3K 0.01% 273
2024
Q2
$218K Sell
1,375
-250
-15% -$37K 0.01% 266
2024
Q1
$236K Buy
1,625
+75
+5% +$10.7K 0.01% 290
2023
Q4
$220K Buy
+1,550
New +$193K 0.01% 281
2020
Q1
Sell
-3,725
Closed -$305K 190
2019
Q4
$305K Buy
3,725
+50
+1% +$3.93K 0.03% 169
2019
Q3
$288K Sell
3,675
-625
-15% -$48.4K 0.03% 182
2019
Q2
$322K Hold
4,300
0.03% 173
2019
Q1
$299K Sell
4,300
-50
-1% -$3.57K 0.02% 184
2018
Q4
$299K Sell
4,350
-200
-4% -$14.7K 0.02% 185
2018
Q3
$361K Hold
4,550
0.03% 178
2018
Q2
$369K Buy
4,550
+50
+1% +$4.21K 0.03% 182
2018
Q1
$374K Buy
+4,500
New +$354K 0.03% 169

Other funds holding BKNG

Aspiriant LLC's BKNG Position: Q1 2026 in Review

Aspiriant LLC reduced its Booking.com (BKNG) stake by 25% in Q1 2026, selling an estimated $78.2K and leaving 1,300 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #323.

Aspiriant LLC first reported a position in BKNG in Q1 2018 and has held it in 18 quarters since. The position peaked at $411K in Q2 2025. 1,907 funds tracked by Wall St. Rank hold BKNG as of Q1 2026.

  • Aspiriant LLC held 1,300 shares of Booking.com worth $219K as of Q1 2026.
  • Aspiriant LLC sold 425 Booking.com shares in Q1 2026, an estimated $78.2K.
  • Booking.com made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #323 holding.
  • Aspiriant LLC first reported a position in Booking.com in Q1 2018 and has held it in 18 quarters since.
  • Aspiriant LLC's Booking.com position peaked at $411K in Q2 2025.
  • 1,907 funds tracked by Wall St. Rank held Booking.com as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.